Company: DMAAR
Filing Date: 2025-01-14
Form Type: POS AM
Source: 0001213900-25-003137
Chunk: 287

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-01-14
Form: POS AM
Chunk 287
---
mates a liquidation, merger, share exchange or other similar transaction which results in all of the shareholders having the right to exchange their ordinary shares for cash, securities or other property. Administrative Support Agreement The Company has entered into an Administrative Services Agreement pursuant to which the Company has agreed to pay the Sponsor or an affiliate $10,000 for office space, and administrative and support services. Upon completion of the initial business combination or the Company’s liquidation, the administrative services agreement will terminate, and the Company will cease paying these monthly fees. F-12 DRUGS MADE IN AMERICA ACQUISITION CORP.
NOTES TO FINANCIAL STATEMENTS
MAY 23, 2024 (INCEPTION) THROUGH SEPTEMBER 30, 2024 NOTE 5 — RELATED PARTIES (cont.) Promissory Note — Related Party On June 13, 2024, the Sponsor issued an unsecured promissory note to the Company (the “Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $500,000. On November21, 2024, the Sponsor amended the Promissory Note to increase the amount the Company may borrow to $750,000 (see Note 8). On December5, 2024, the Sponsor further amended the Promissory Note to increase the amount the Company may borrow to $1,850,000 (see Note 8). The Promissory Note is non -interestbearing and shall be due and payable upon the closing of the Company’s initial business combination or upon the Company’s dissolution, whichever occurs first. During the period from May23, 2024 (inception) through June30, 2024, the Company received funds totaling approximately $410,000 from various investors on behalf of the Sponsor. During the period from May23, 2024 (inception) through September30, 2024, the Company received funds totaling approximately $1,700,000 from various investors on behalf of the Sponsor. These monies represent advances paid to the Sponsor for purchase of Founder Shares upon successful completion of the Proposed Public Offering. The monies were received on behalf of the Sponsor and deposited into the Company’s bank account instead of the Sponsor’s bank account. During the period from May23, 2024 (inception) through June30, 2024, the Company repaid approximately $225,000 of the balance due to the Sponsor related to investments it had received on behalf of the